# Immunopathology for NEET PG Pathology: Hypersensitivity Types, HLA, Transplant Rejection, SLE, Complement, HIV/AIDS

Source: https://tracknation.in/story/immunopathology-for-neet-pg-pathology-hypersensitivity-types-hla-transplant-rejection-sle-complement-hiv-aids (TrackNation — free UPSC notes with PYQs)

> NEET PG Pathology: Gell and Coombs hypersensitivity types with examples, autoimmunity mechanisms, HLA classes and disease links, transplant rejection, SLE antibodies, complement deficiencies and hereditary angioedema, and HIV/AIDS with India's NACO testing and Treat All policy, with a diagram, hooks, vignette MCQs and cards.

## Start Here

🎯 **Exam priority: Very high.** *Expect: classify a disease by hypersensitivity type, HLA–disease pairs, rejection by timing,
SLE antibodies, complement deficiencies, and HIV entry and CD4 thresholds.*

CBME mapping: **PA 8.1–8.6**.

*Gell and Coombs hypersensitivity types, HLA classes and kidney transplant rejection. Drawn by TrackNation.*

## The Four Hypersensitivities

- **Type I (immediate)**: antigen cross-links IgE on mast cells and basophils, releasing histamine, leukotrienes and other
mediators within an hour. All atopic disorders, anaphylaxis, urticaria. Anaphylaxis is confirmed by serum tryptase, ideally within 2 hours.

- **Type II (antibody against cells)**: antibody bound to a cell-surface antigen triggers complement or ADCC — hyperacute
graft rejection, Coombs-positive haemolytic anaemia, Hashimoto thyroiditis, anti-GBM disease.

- **Type III (immune complex)**: circulating antigen–antibody complexes deposit in vessels and tissues — serum sickness, SLE,
rheumatoid arthritis, leukocytoclastic vasculitis, cryoglobulinaemia, several glomerulonephritides.

- **Type IV (delayed, T cell)**: no antibody — contact dermatitis, SJS/TEN, DRESS, the response to tuberculosis, acute and
chronic allograft rejection.

## Autoimmunity and HLA

- Autoimmune diseases use types II, III and IV — never type I. Females are affected more often. Mechanisms: altered self-antigens,
**molecular mimicry** (streptococcal M-protein antibodies cross-react with heart muscle) and **sequestered antigens**
released by injury (sympathetic ophthalmia after eye trauma). HLA variants nearly always contribute.

- **HLA** genes sit on the short arm of chromosome 6. Class I (A, B, C) is on all nucleated cells and presents to CD8 T cells;
its light chain, β2-microglobulin, is coded on chromosome 15. Class II (DP, DQ, DR) is on antigen-presenting cells, thymic epithelium and activated
T cells, and presents to CD4 T cells. Class III region codes C2, C4, factor B and TNF-α. HLA-G in the placenta protects the fetus.

- For transplant matching, HLA-DR matters most, then B, then A.

| **HLA allele (MSD)**

 | **Disease**

 |
| HLA-B27

 | Ankylosing spondylitis, reactive arthritis

 |
| HLA-DR4

 | Rheumatoid arthritis

 |
| HLA-DQ2 and DQ8

 | Type 1 diabetes, coeliac disease

 |
| HLA-DR3

 | SLE, Graves disease, Sjögren

 |
| HLA-B51

 | Behçet syndrome

 |
| HLA-DR2

 | Multiple sclerosis, narcolepsy

 |

## Transplant Rejection

- **Hyperacute** (minutes to hours; HLA incompatibility; antibody-mediated, type II): fever, anuria; usually means graft
failure. **Accelerated** (days; antibody). **Acute** (days to weeks; T cell or antibody): rising creatinine, graft swelling
— usually reversible with pulse steroids. **Chronic** (months to years): proteinuria, hypertension, graft loss.

## SLE and Complement

- **SLE** mainly affects young women. ANA is very sensitive but not specific; **anti-dsDNA** is highly specific.
Hydralazine, procainamide and TNF inhibitors cause drug-induced lupus. Pericarditis is the commonest cardiac lesion; Libman-Sacks endocarditis is rare.
Mothers with anti-Ro (SSA) can have babies with congenital heart block. Antiphospholipid antibodies raise the risk of late miscarriage.

- **Complement**: deficiency of C5–C9, factor B, factor D or properdin → recurrent *Neisseria* infection; defects in
C1, C4 or C5 → SLE. C3a and C5a are anaphylatoxins.

- **Hereditary angioedema** (C1 inhibitor deficiency, autosomal dominant): swelling without itching, urticaria or bronchospasm,
but laryngeal oedema can kill.

## HIV and AIDS

- **Entry**: gp120 binds CD4, then a co-receptor (CCR5 or CXCR4); gp41 fuses the envelope. Reverse transcriptase turns the RNA
genome into DNA.

- **Advanced disease**: CD4 < 200/µL (or < 14%) or an AIDS-defining infection or cancer. Below 200: Pneumocystis,
toxoplasma, Cryptococcus. Below 50: CMV and Mycobacterium avium complex.

- **India (NACO)**: Strategy III uses three rapid tests in sequence — negative if the first is non-reactive, positive only if all
three are reactive. ART is started for everyone regardless of CD4 count or stage ("Treat All", since 2017).

## Traps the Examiner Sets

- Hyperacute rejection = type II; acute and chronic rejection = type IV (MSD).

- Hashimoto and anti-GBM = type II; SLE and serum sickness = type III; TB and contact dermatitis = type IV.

- ANA = sensitive; anti-dsDNA = specific.

- C5–C9 deficiency = Neisseria; HAE = no urticaria.

## Memory Hooks & Shortcuts

*Shortcuts to lock in this article's numbers and lists. Each one only re-packages facts proven above.*

- 🧠 **ACID: Anaphylactic, Cytotoxic, Immune complex, Delayed** — types I to IV in order

- 🧠 **Hyperacute is Hurried antibody (II); later rejection is T-cell (IV)** — rejection types

- 🧠 **DR before B before A — 'Doctors Before Assistants'** — HLA matching priority

- 🧠 **B27 bends the Back** — HLA-B27, ankylosing spondylitis

- 🧠 **ANA = Any lupus? dsDNA = Definitely SLE** — sensitive vs specific

- 🧠 **Terminal complement gone, Neisseria comes** — C5–C9 deficiency

- 🧠 **Two hundred: Pneumocystis; fifty: CMV and MAC** — CD4 thresholds

## Rapid-Revision Cards

- IgE, mast cells; < 1 h; atopy, anaphylaxis.

- Serum tryptase within 2 h.

- Antibody on cells: hyperacute rejection, Coombs+ haemolysis, Hashimoto, anti-GBM.

- Immune complexes: serum sickness, SLE, RA, vasculitis.

- T cells: contact dermatitis, TB, SJS/TEN, DRESS, acute/chronic rejection.

- Type I.

- Streptococcal M protein vs heart.

- Sympathetic ophthalmia.

- Chromosome 6p; β2m on 15.

- All nucleated cells/CD8 vs APCs/CD4.

- C2, C4, factor B, TNF-α.

- DR > B > A.

- Ankylosing spondylitis, reactive arthritis.

- Coeliac, type 1 diabetes.

- Rheumatoid arthritis.

- Minutes–hours; HLA antibody; graft lost.

- ANA sensitive; anti-dsDNA specific.

- Hydralazine, procainamide, TNF inhibitors.

- Congenital heart block.

- Neisseria.

- C1-INH; AD; no urticaria; larynx.

- gp120–CD4 + CCR5/CXCR4; gp41 fusion.

- < 200 PCP, toxo, crypto; < 50 CMV, MAC.

- Strategy III: 3 tests all reactive; Treat All since 2017.

## Sources

*Facts in this article were checked against these documents.*

- MSD Manual Professional: Overview of Allergic and Atopic Disorders; Anaphylaxis; Autoimmune Disorders; HLA System; Complement System; C1 Inhibitor Deficiency — Merck & Co. (MSD Manuals), reviewed 2025–26 (link)

- MSD Manual Professional: Kidney Transplantation; Systemic Lupus Erythematosus; HIV Infection — Merck & Co. (MSD Manuals), reviewed 2025–26 (link)

- National Guidelines for HIV Counselling and Testing Services — National AIDS Control Organisation, MoHFW, 2024 (link)

- National Guidelines for HIV Care and Treatment — National AIDS Control Organisation, MoHFW, 2021 (link)

- Competency Based Undergraduate Curriculum, Pathology (PA 8) — National Medical Commission, 2024

## Test Yourself: Practice Questions

Thirty-three questions in NEET PG style, most of them clinical vignettes.

## Practice Questions (NEET PG pattern)

*Original questions written in the style of the exam: +4 for a correct answer, −1 for a wrong one. Every answer
was checked against the sources listed above. NEET PG papers are not published by NBEMS, so these are not past-paper questions.*

**Q1.** Within minutes of a bee sting, a man develops hives, wheeze and hypotension. The mechanism is

- (a) immune complexes (type III)

- (b) IgE on mast cells and basophils (type I)

- (c) antibody against red cells (type II)

- (d) T cells (type IV)

**Answer: (b)** — Type I reactions develop within an hour.

**Q2.** Hours after a suspected anaphylactic reaction, the test that best confirms it is

- (a) ANA

- (b) serum IgG

- (c) serum tryptase (ideally within 2 hours)

- (d) complement C3

**Answer: (c)** — Diagnosis is mainly clinical.

**Q3.** All atopic disorders, such as allergic asthma and allergic rhinitis, are

- (a) type III

- (b) type IV

- (c) type II

- (d) type I hypersensitivity

**Answer: (d)** — Atopy = exaggerated IgE response.

**Q4.** Anti-glomerular basement membrane disease is classified by MSD as

- (a) type III

- (b) type I

- (c) type IV

- (d) type II hypersensitivity

**Answer: (d)** — Antibody against a fixed tissue antigen.

**Q5.** A woman has warm autoimmune haemolytic anaemia with a positive direct Coombs test. The hypersensitivity type is

- (a) type I

- (b) type II

- (c) type III

- (d) type IV

**Answer: (b)** — Antibody on the cell surface.

**Q6.** A patient develops serum sickness after receiving a foreign protein. The mechanism is

- (a) immune-complex deposition (type III, serum sickness)

- (b) antibody against red cells (type II)

- (c) IgE (type I)

- (d) T cells (type IV)

**Answer: (a)** — Type III can develop hours to weeks after exposure.

**Q7.** In MSD's classification, SLE and rheumatoid arthritis are

- (a) not hypersensitivity disorders

- (b) type III (immune complex) disorders

- (c) type IV

- (d) type I

**Answer: (b)** — Also leukocytoclastic vasculitis, cryoglobulinaemia.

**Q8.** A gardener develops contact dermatitis from a plant such as poison ivy. The mechanism is

- (a) IgE (type I)

- (b) T-cell mediated (type IV)

- (c) complement deficiency

- (d) immune complex (type III)

**Answer: (b)** — Contact dermatitis (e.g. poison ivy).

**Q9.** A patient develops Stevens-Johnson syndrome after starting a new drug. The hypersensitivity type is

- (a) type I

- (b) type II

- (c) type III

- (d) type IV

**Answer: (d)** — Also TEN and DRESS.

**Q10.** The tuberculin reaction and the granulomatous response to tuberculosis are examples of

- (a) type II

- (b) type I

- (c) type III

- (d) type IV hypersensitivity

**Answer: (d)** — Delayed, T-cell mediated, no antibody.

**Q11.** Which hypersensitivity type is NOT involved in autoimmune disease?

- (a) type I

- (b) type III

- (c) type IV

- (d) type II

**Answer: (a)** — Autoimmunity uses types II, III and IV.

**Q12.** After a streptococcal throat infection, antibodies against streptococcal M protein attack the heart. The mechanism is

- (a) sequestered antigen release

- (b) complement deficiency

- (c) IgE release

- (d) molecular mimicry (cross-reaction)

**Answer: (d)** — Antibodies to a foreign antigen cross-react with self.

**Q13.** After an injury to one eye, a patient develops sympathetic ophthalmia. The mechanism is

- (a) complement consumption

- (b) molecular mimicry

- (c) IgE

- (d) release of a sequestered antigen (sympathetic ophthalmia)

**Answer: (d)** — Melanin-containing uveal cells released after trauma.

**Q14.** HLA class I molecules are found on

- (a) only B cells

- (b) all nucleated cells, presenting to CD8 T cells

- (c) red cells only

- (d) only antigen-presenting cells

**Answer: (b)** — Class II is on APCs and presents to CD4 T cells.

**Q15.** The light chain of HLA class I (β2-microglobulin) is coded on chromosome

- (a) 17

- (b) 15

- (c) 11

- (d) 6

**Answer: (b)** — The HLA genes themselves are on 6p.

**Q16.** HLA class II (DP, DQ, DR) molecules present antigen to

- (a) CD4 helper T cells

- (b) red cells

- (c) NK cells only

- (d) CD8 cytotoxic T cells

**Answer: (a)** — On B cells, macrophages, dendritic cells, thymic epithelium, activated T cells.

**Q17.** Which genes lie in the HLA class III region?

- (a) complement C2, C4, factor B and TNF-α

- (b) the T-cell receptor

- (c) β2-microglobulin

- (d) immunoglobulin heavy chains

**Answer: (a)** — MSD.

**Q18.** For a kidney transplant, the HLA locus that matters most for matching is

- (a) HLA-A

- (b) HLA-C

- (c) HLA-G

- (d) HLA-DR

**Answer: (d)** — Then HLA-B, then HLA-A.

**Q19.** A young man is diagnosed with ankylosing spondylitis. The HLA allele most associated is

- (a) HLA-DQ2

- (b) HLA-B27

- (c) HLA-B51

- (d) HLA-DR4

**Answer: (b)** — Ankylosing spondylitis and reactive arthritis.

**Q20.** Coeliac disease and type 1 diabetes are both associated with

- (a) HLA-B27

- (b) HLA-B51

- (c) HLA-DR2

- (d) HLA-DQ2 and DQ8

**Answer: (d)** — RA: DR4; Behçet: B51.

**Q21.** Minutes after a kidney transplant is connected, the patient becomes febrile and anuric. This is

- (a) chronic rejection

- (b) hyperacute rejection from HLA incompatibility

- (c) calcineurin toxicity

- (d) acute T-cell rejection

**Answer: (b)** — Usually means graft failure; MSD classes it as type II.

**Q22.** Years after a kidney transplant, a patient has slowly rising proteinuria and hypertension. This is

- (a) chronic rejection (T cell or antibody)

- (b) type I hypersensitivity

- (c) hyperacute rejection

- (d) accelerated rejection

**Answer: (a)** — May end in graft loss.

**Q23.** A young woman has arthritis, a facial rash and a positive ANA. The test that is highly specific for SLE is

- (a) ESR

- (b) rheumatoid factor

- (c) anti-dsDNA

- (d) ANA titre

**Answer: (c)** — ANA is very sensitive but not specific.

**Q24.** A man on long-term hydralazine develops arthralgia and a positive ANA. This is

- (a) rheumatoid arthritis

- (b) serum sickness

- (c) drug-induced lupus (resolves when the drug is stopped)

- (d) primary SLE needing lifelong steroids

**Answer: (c)** — Also procainamide and TNF inhibitors.

**Q25.** A newborn has congenital complete heart block. The mother's blood should be tested for

- (a) anti-CCP

- (b) anti-GBM

- (c) anti-dsDNA

- (d) anti-Ro (SSA) antibodies

**Answer: (d)** — Neonatal lupus.

**Q26.** The commonest cardiac complication of SLE is

- (a) pericarditis

- (b) Libman-Sacks endocarditis

- (c) aortic stenosis

- (d) coronary vasculitis

**Answer: (a)** — Libman-Sacks is rare.

**Q27.** A young adult has a second episode of meningococcal meningitis. A defect to look for is deficiency of

- (a) IgE

- (b) C1 inhibitor

- (c) CD4 cells

- (d) a terminal complement component (C5–C9)

**Answer: (d)** — Also factor B, factor D, properdin.

**Q28.** Defects in early classical-pathway components (C1, C4) predispose to

- (a) hereditary angioedema

- (b) systemic lupus erythematosus

- (c) asthma

- (d) Neisseria infection only

**Answer: (b)** — MSD complement table.

**Q29.** A teenager has recurrent episodes of painful swelling and abdominal colic, never with itching or hives; her father has the same. The defect is

- (a) mast cell disease

- (b) C1 inhibitor deficiency (hereditary angioedema, autosomal dominant)

- (c) IgE-mediated food allergy

- (d) C5 deficiency

**Answer: (b)** — Laryngeal oedema can be fatal.

**Q30.** HIV enters a CD4 T cell when gp120 binds CD4 and then a co-receptor, which is

- (a) CCR5 or CXCR4

- (b) CD8

- (c) HLA class I

- (d) the IgE receptor

**Answer: (a)** — gp41 then mediates fusion.

**Q31.** A person with HIV has a CD4 count of 150/µL and develops pneumonia. The infection that becomes likely below 200 cells/µL is

- (a) CMV retinitis only

- (b) Mycobacterium avium complex only

- (c) Pneumocystis jirovecii pneumonia

- (d) influenza only

**Answer: (c)** — Below 50: CMV and MAC.

**Q32.** Under NACO Strategy III for the general population, a person is reported HIV-positive when

- (a) any two tests are reactive

- (b) all three rapid tests are reactive

- (c) a single ELISA is reactive

- (d) the first test is reactive

**Answer: (b)** — Negative if the first test is non-reactive.

**Q33.** Under India's national programme, a newly diagnosed adult with HIV and a CD4 count of 700/µL should

- (a) wait until CD4 < 200

- (b) start ART now — Treat All, regardless of CD4 or stage

- (c) wait until CD4 < 350

- (d) start only if symptomatic

**Answer: (b)** — Treat All since 2017; same-day start offered.

### Active Recall

From memory: give the mechanism and two examples of each hypersensitivity type; explain molecular mimicry and sequestered antigens; compare HLA class I and II and name four HLA–disease links; describe the rejection categories; list SLE antibodies and complement deficiencies; and outline HIV entry, CD4 thresholds and NACO testing and treatment policy.
